APOG
Apogee Enterprises, Inc.
APOG's outlook is improving, though it still trails on the overall score.
VRT
Vertiv Holdings Co
VRT has the edge over APOG overall, supported by stronger valuation and stronger modeled upside.
APOG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
APOG's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
APOG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $33.73 | -29% |
| Forward | 14x | $47.41 | — |
| Fair | 15x | $46.28 | -2.4% |
| Current | 15x | $47.41 | — |
| Expensive | 44x | $139 | +193% |
Historical ranges are pointers, not guarantees.
APOG's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over APOG in the historical PE scenario, which offers more potential upside but is not a forecast.
APOG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for APOG, with profitability holding steady.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
VRT has the edge over APOG on the outlook, with more favorable profitability expectations.
APOG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.37 | +6.6% |
| Q3 2026 | $3.16 | +54% |
| Q2 2026 | $3.19 | +36% |
| Q1 2026 | $2.52 | -35% |
| Q4 2025 | $1.86 | -58% |
| Q3 2025 | $2.05 | -57% |
| Q2 2025 | $2.35 | -52% |
| Q1 2025 | $3.89 | -14% |
| Q4 2024 | $4.48 | -4.5% |
APOG's earnings per share have fallen from their peak: $3.16 over the past year, against $4.87 in mid-2024.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over APOG on earnings, with more consistent year-over-year improvement.
APOG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $391.1M | +9.2% |
| Q2 2026 | $342.7M | -1.1% |
| Q1 2026 | $351.4M | +1.6% |
| Q4 2025 | $348.6M | +2.1% |
| Q3 2025 | $358.2M | +4.6% |
| Q2 2025 | $346.6M | +4.6% |
| Q1 2025 | $345.7M | -4.5% |
| Q4 2024 | $341.3M | +0.5% |
APOG's revenue grew through 2022 and has held roughly level since: $391M last quarter, up 9.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.6% | +1.1 points |
| Q2 2026 | 5.5% | +3.5 points |
| Q1 2026 | 7.3% | +5.6 points |
| Q4 2025 | 7.1% | -1.3 points |
| Q3 2025 | 7.5% | -4.7 points |
| Q2 2025 | 2% | -11 points |
| Q1 2025 | 1.8% | -4.3 points |
| Q4 2024 | 8.4% | -2.7 points |
APOG's operating margin was 8.6% last quarter, up 1.1 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over APOG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over APOG on profitability, with a higher operating margin.
APOG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $24.3M | -54% |
| Q2 2026 | $1.1M | +$28.1M |
| Q1 2026 | $46.9M | +145% |
| Q4 2025 | $22.9M | +4.1% |
| Q3 2025 | $52.4M | +4.3% |
| Q2 2025 | -$26.9M | -$25.2M |
| Q1 2025 | $19.1M | -67% |
| Q4 2024 | $22M | -60% |
APOG still generates free cash flow, though less than at its 2024 peak: $95M over the past year.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over APOG on cash flow, with more consistent year-over-year improvement.
APOG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.9% | -411K shares |
| 1 year | -3.2% | -689K shares |
| 3 years | -4.8% | -1.1M shares |
| 5 years | -17% | -4.2M shares |
| Available history | -22% | -5.8M shares |
APOG has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.4M |
| Q2 2026 | $9.7M |
| Q1 2026 | $15M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $30.3M |
| Q4 2024 | — |
APOG spent $31M buying back its own shares over the past year, up 2.6% from the year before.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
APOG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 2.0x | Healthy |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.3x | Healthy |
APOG's net debt is about 1.9 years of its operating earnings (EBITDA), about the same as a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over APOG on leverage, with a lower net debt burden relative to earnings.
APOG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.6 | Neutral |
| Stochastic | 85.8 | Overbought |
APOG's weekly RSI is 64 (neutral) and its Stochastic is 86 (overbought).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
APOG PE vs Industrials Sector
| Metric | APOG | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 24x | 38% below |
| PE % | 52 | 58 | 6 pts below |
APOG has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
APOG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $42.1 | 13% above |
| 20 week MA | $41.0 | 16% above |
| 50 week MA | $39.0 | 22% above |
| 100 week MA | $42.0 | 13% above |
| 200 week MA | $48.7 | 2.6% below |
APOG has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
APOG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.5 | $32.7 | +0.5% |
| 2021 | $32.7 | $47.2 | +44% |
| 2022 | $47.2 | $43.9 | -7% |
| 2023 | $43.9 | $53.4 | +22% |
| 2024 | $53.4 | $72.3 | +35% |
| 2025 | $72.3 | $38.0 | -48% |
| 2026 YTD | $38.0 | $47.4 | +25% |
APOG has finished higher in four of the last six years. It's up 25% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over APOG on returns for 2026, with the stronger performance.